DE19757767A1 - Immunreaktive Bereiche des Glycoproteins gpII des Varicella-Zoster-Virus (VZV) - Google Patents

Immunreaktive Bereiche des Glycoproteins gpII des Varicella-Zoster-Virus (VZV)

Info

Publication number
DE19757767A1
DE19757767A1 DE19757767A DE19757767A DE19757767A1 DE 19757767 A1 DE19757767 A1 DE 19757767A1 DE 19757767 A DE19757767 A DE 19757767A DE 19757767 A DE19757767 A DE 19757767A DE 19757767 A1 DE19757767 A1 DE 19757767A1
Authority
DE
Germany
Prior art keywords
vzv
gpii
nucleic acid
immunoreactive
immunoreactive peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19757767A
Other languages
German (de)
English (en)
Inventor
Markus Dr Eickmann
Dorothee Gicklhorn
Klaus Prof Dr Radsak
Hans-Peter Dr Hauser
Bernhard Dr Giesendorf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Dade Behring Marburg GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dade Behring Marburg GmbH filed Critical Dade Behring Marburg GmbH
Priority to DE19757767A priority Critical patent/DE19757767A1/de
Priority to EP98122351A priority patent/EP0927760B1/de
Priority to DE59814427T priority patent/DE59814427D1/de
Priority to ES98122351T priority patent/ES2341061T3/es
Priority to AT98122351T priority patent/ATE453715T1/de
Priority to CA002255101A priority patent/CA2255101C/en
Priority to JP36493398A priority patent/JP4163799B2/ja
Priority to US09/219,797 priority patent/US6414116B1/en
Publication of DE19757767A1 publication Critical patent/DE19757767A1/de
Priority to US10/127,733 priority patent/US6960442B2/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE19757767A 1997-12-23 1997-12-23 Immunreaktive Bereiche des Glycoproteins gpII des Varicella-Zoster-Virus (VZV) Withdrawn DE19757767A1 (de)

Priority Applications (9)

Application Number Priority Date Filing Date Title
DE19757767A DE19757767A1 (de) 1997-12-23 1997-12-23 Immunreaktive Bereiche des Glycoproteins gpII des Varicella-Zoster-Virus (VZV)
EP98122351A EP0927760B1 (de) 1997-12-23 1998-11-25 Immunreaktive Bereiche des Glycoproteins gpII des Varicella Zoster-Virus (VZV)
DE59814427T DE59814427D1 (de) 1997-12-23 1998-11-25 Immunreaktive Bereiche des Glycoproteins gpII des Varicella Zoster-Virus (VZV)
ES98122351T ES2341061T3 (es) 1997-12-23 1998-11-25 Regiones inmunorreactivas de la glicoproteina gpii del virus de la varicela zoster (vzv).
AT98122351T ATE453715T1 (de) 1997-12-23 1998-11-25 Immunreaktive bereiche des glycoproteins gpii des varicella zoster-virus (vzv)
CA002255101A CA2255101C (en) 1997-12-23 1998-12-16 Immunoreactive regions of glycoprotein gpii of varicella zoster virus (vzv)
JP36493398A JP4163799B2 (ja) 1997-12-23 1998-12-22 水痘帯状疱疹ウイルス（ＶＺＶ）の糖タンパク質ｇｐＩＩの免疫反応性領域
US09/219,797 US6414116B1 (en) 1997-12-23 1998-12-23 Immunoreactive regions of glycoprotein GPII of varicella zoster virus
US10/127,733 US6960442B2 (en) 1997-12-23 2002-04-23 Immunoreactive regions of glycoprotein gpII of varicella zoster virus (VZV)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19757767A DE19757767A1 (de) 1997-12-23 1997-12-23 Immunreaktive Bereiche des Glycoproteins gpII des Varicella-Zoster-Virus (VZV)

Publications (1)

Publication Number Publication Date
DE19757767A1 true DE19757767A1 (de) 1999-07-15

Family

ID=7853319

Family Applications (2)

Application Number Title Priority Date Filing Date
DE19757767A Withdrawn DE19757767A1 (de) 1997-12-23 1997-12-23 Immunreaktive Bereiche des Glycoproteins gpII des Varicella-Zoster-Virus (VZV)
DE59814427T Expired - Lifetime DE59814427D1 (de) 1997-12-23 1998-11-25 Immunreaktive Bereiche des Glycoproteins gpII des Varicella Zoster-Virus (VZV)

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE59814427T Expired - Lifetime DE59814427D1 (de) 1997-12-23 1998-11-25 Immunreaktive Bereiche des Glycoproteins gpII des Varicella Zoster-Virus (VZV)

Country Status (7)

Country Link
US (2) US6414116B1 (enExample)
EP (1) EP0927760B1 (enExample)
JP (1) JP4163799B2 (enExample)
AT (1) ATE453715T1 (enExample)
CA (1) CA2255101C (enExample)
DE (2) DE19757767A1 (enExample)
ES (1) ES2341061T3 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19757767A1 (de) * 1997-12-23 1999-07-15 Dade Behring Marburg Gmbh Immunreaktive Bereiche des Glycoproteins gpII des Varicella-Zoster-Virus (VZV)
JP2001074333A (ja) 1999-09-03 2001-03-23 Daikin Ind Ltd ヒートポンプ
CN1989789A (zh) * 2004-07-21 2007-06-27 皇家飞利浦电子股份有限公司 用于气体放电灯的多脉冲点火电路
US12569553B2 (en) 2020-03-09 2026-03-10 Dynavax Technologies Corporation Shingles vaccines comprising a TLR9 agonist

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3717772A (en) 1971-09-03 1973-02-20 Midland Capital Corp Linear bidirectional scanning system
US4686101A (en) * 1985-08-02 1987-08-11 Merck & Co., Inc. Vaccine against varicella-zoster virus
ATE116860T1 (de) * 1988-08-01 1995-01-15 Akzo Nobel Nv Pseudorabiesvirus-impfstoff.
ATE119939T1 (de) 1989-06-27 1995-04-15 Smithkline Beecham Biolog Verbindungen.
JPH07199A (ja) * 1993-06-18 1995-01-06 Teijin Ltd 水痘帯状疱疹ウイルス検出用プライマーセット及びそれを用いる同ウイルスの検出方法
DE19757767A1 (de) * 1997-12-23 1999-07-15 Dade Behring Marburg Gmbh Immunreaktive Bereiche des Glycoproteins gpII des Varicella-Zoster-Virus (VZV)

Also Published As

Publication number Publication date
JPH11248710A (ja) 1999-09-17
CA2255101C (en) 2009-06-16
DE59814427D1 (de) 2010-02-11
US6414116B1 (en) 2002-07-02
ATE453715T1 (de) 2010-01-15
EP0927760A3 (de) 2000-10-11
EP0927760B1 (de) 2009-12-30
CA2255101A1 (en) 1999-06-23
EP0927760A2 (de) 1999-07-07
ES2341061T3 (es) 2010-06-14
US20020150889A1 (en) 2002-10-17
US6960442B2 (en) 2005-11-01
JP4163799B2 (ja) 2008-10-08

Similar Documents

Publication Publication Date Title
Li et al. The Epstein-Barr virus (EBV) BZLF2 gene product associates with the gH and gL homologs of EBV and carries an epitope critical to infection of B cells but not of epithelial cells
DE3882522T2 (de) Baculovirus-Transfervektoren.
Crabb et al. Epitopes of glycoprotein G of equine herpesviruses 4 and 1 located near the C termini elicit type-specific antibody responses in the natural host
DE69017769T2 (de) Verbindungen.
DE3686304T2 (de) Typenspezifische papillomavirus-dns-sequenzen und peptide.
US5451499A (en) Attenuated, genetically-engineered pseudorabies virus S-PRV-155 and uses thereof
Black et al. Frequent isolation of human herpesvirus 7 from saliva
DE69334191T2 (de) Epstein-Barr-Virus verwandte Peptide und Nukleinsäuresegmente
EP0236145B1 (en) Processes for the production of hcmv glycoproteins, antibodies thereto and hcmv vaccines, and recombinant vectors therefor
DE69230812T2 (de) Verfahren zum Nachweis einer Rinderdiarrhoe- virusinfektion, für ein durch eine Infektion mit diesem Virus induziertes Eiweiss kodierende Nukleotidsequenz, sowie daraus abgeleitete rekombinante Eiweisse und Antigene
WO1990010230A1 (en) Polypeptide having immunological activity for use as diagnostic reagent and/or vaccine
DE69734387T2 (de) Ein kombiniertes antigen vom menschlichen cytomegalievirus und seine anwendung
EP0252531B1 (de) Strukturelles Phosphoprotein (pp 150) des menschlichen Cytomegalovirus, seine Herstellung und Verwendung
DE69614393T2 (de) Herpes simplex viren diagnostik
EP0210931A2 (en) Vaccine against varicella-zoster virus
KR100224331B1 (ko) 조환수두 대상포진바이러스 및 그 제작방법
EP0927760B1 (de) Immunreaktive Bereiche des Glycoproteins gpII des Varicella Zoster-Virus (VZV)
US6162620A (en) Processes for the production of HCMV glycoproteins, antibodies thereto and HCMV vaccines, and recombinant vectors therefor
DE69132404T2 (de) Varicella-zoster virusantigen
EP0927759B1 (de) Immunreaktives Protein VP26 des Varicella-Zoster-Virus (VZV) und seine diagnostische Verwendung
EP0547446B1 (de) Impfstoffe auf Basis geänderter Boviner Herpesviren Typ 1
DE69232975T2 (de) Protein p100von menschlichem Herpesvirus Typ 6, die korrespondierenden DNS Squenzen, ihre Herstellung und Verwendung
EP0893504B1 (de) Von Kaposi-sarkom assoziiertem Herpes-Virus (KSHV, HHV-8) kodiertes Polypeptid und dessen Verwendung in Diagnostik und Therapie
DE69330966T2 (de) DNA-Sequenzen des Epstein-Barr Virus kodierend für ein diagnostisch relevantes Virus-Hüllprotein, durch PCR erhaltene Expressionsklone und Verwendung dieses rekombinanten Antigens in diagnostischen Tests
EP0926155A2 (de) Polypeptide mit Aminosäuresequenzen aus dem N-terminalen Bereich von gp116 von Cytomegalovirus und deren Verwendung bei der Diagnostik, Prophylaxe und Therapie

Legal Events

Date Code Title Description
8141 Disposal/no request for examination